Adviser
Lucid.
Fairness opinion, Financial adviser on 5 live deals, from 28 Apr 2025 to 3 Dec 2025.
05Live deals
03Other advisers
Deals
| Date | Deal | Stage | Role | Sector |
|---|---|---|---|---|
| 3 Dec 2025 | Hyperliquid Strategies Inc / Sonnet BioTherapeutics Holdings, Inc. | Closed |
| Not stated |
| 27 Oct 2025 | Biossil Inc. / Galera Therapeutics, Inc. | Agreement signed |
| Not stated |
| 20 Aug 2025 | XOMA Royalty Corporation / Mural Oncology plc | Agreement signed |
| Healthcare |
| 20 Aug 2025 | XRA 5 Corp. / Mural | Agreement signed |
| Healthcare |
| 28 Apr 2025 | Crescent / GlycoMimetics, Inc. | Agreement signed |
| Not stated |
By year, sector and stage
| 2025 | 5 |
|---|
| Not stated | 3 |
|---|---|
| Healthcare | 2 |
| Agreement signed | 4 |
|---|---|
| Closed | 1 |
Other advisers on the same deals
| Adviser | Shared deals | Across the table | Alongside |
|---|---|---|---|
| Lucid Capital Markets, LLC | 2 | 0 | 2 |
| Lowenstein Sandler LLP | 1 | 0 | 1 |
| Scheme Shareholders | 1 | 0 | 1 |